Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Post-approval studies (Phase 4)Study completedNCT02099084
What this trial is testing

Short Bowel Syndrome and Teduglutide Versus Placebo

Who this might be right for
Short Bowel Syndrome
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT03841526
What this trial is testing

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Who this might be right for
Hypoglycemia
Xeris Pharmaceuticals 48
Not applicableStudy completedNCT06722326
What this trial is testing

Hydrogen-rich Water and Appetite in Obesity

Who this might be right for
Obesity
University of Novi Sad, Faculty of Sport and Physical Education 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07073417
What this trial is testing

Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Who this might be right for
ObesityWeight Management
Hangzhou Sciwind Biosciences Co., Ltd. 163
Testing effectiveness (Phase 2)Study completedNCT05920889
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies

Who this might be right for
StrokeStroke, AcuteStroke, Ischemic+1 more
Chinese University of Hong Kong 140
Early research (Phase 1)Study completedNCT02692040
What this trial is testing

Study of the Gut Hormone Analogue G3215 in Adult Subjects

Who this might be right for
Diabetes MellitusObesity
Imperial College London 90
Testing effectiveness (Phase 2)Study completedNCT00566358
What this trial is testing

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

Who this might be right for
Diabetes Mellitus, Type 2
University of Campinas, Brazil 18
Not applicableStudy completedNCT02337660
What this trial is testing

Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia

Who this might be right for
Non-alcoholic Fatty Liver Disease
University Hospital, Gentofte, Copenhagen 30
Testing effectiveness (Phase 2)Study completedNCT02975297
What this trial is testing

Exenatide Once Weekly for Smoking Cessation

Who this might be right for
Smoking Cessation
The University of Texas Health Science Center, Houston 84
Post-approval studies (Phase 4)Study completedNCT03717688
What this trial is testing

The Effects of Neprilysin on Glucagon-like Peptide-1

Who this might be right for
DiabetesHeart Failure
Nicolai Jacob Wewer Albrechtsen 19
Early research (Phase 1)Study completedNCT00823940
What this trial is testing

Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 42
Large-scale testing (Phase 3)Study completedNCT02092896
What this trial is testing

Liraglutide as add-on to Insulin in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Hvidovre University Hospital 40
Large-scale testing (Phase 3)Study completedNCT01722266
What this trial is testing

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
University at Buffalo 72
Early research (Phase 1)Study completedNCT02086227
What this trial is testing

Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)

Who this might be right for
Hypoglycemia
Fresenius Kabi USA, LLC 32
Testing effectiveness (Phase 2)Ended earlyNCT00798590
What this trial is testing

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Who this might be right for
Critically IllHypoglycemia
Johns Hopkins University 19
Not applicableUnknownNCT02637388
What this trial is testing

Effects of Beta-glucan on Energy Intake and Satiety

Who this might be right for
Obesity
Queen Margaret University 36
Large-scale testing (Phase 3)Study completedNCT04039503
What this trial is testing

Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 475
Not applicableStudy completedNCT06333496
What this trial is testing

Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans

Who this might be right for
Blood Sugar; HighOverweight and ObesityFat Burn+2 more
Alpine Biotech LLC 12
Not applicableUnknownNCT06154096
What this trial is testing

Liver Fat and Glucagon Resistance

Who this might be right for
Steatosis of Liver
Imperial College London 20
Next Page